• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清学活动的临床静止系统性红斑狼疮:临床与血清学特征之间的不一致

Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.

作者信息

Gladman D D, Urowitz M B, Keystone E C

出版信息

Am J Med. 1979 Feb;66(2):210-5. doi: 10.1016/0002-9343(79)90529-1.

DOI:10.1016/0002-9343(79)90529-1
PMID:218447
Abstract

The significance of abnormal serologic tests in systemic lupus erythematosus (SLE) in the absence of active clinical disease is unclear. In this report we describe a group of 14 patients with SLE in whom a discordance between clinical and serologic features was apparent. These patients had persistently positive lupus erythematosus preparations and antinuclear antibody tests, low serum complement levels and high levels of DNA binding. Their lymphocyte response to concanavalin A (Con A) mitogen was suppressed. They have been asymptomatic and have remained untreated for a mean of four and a quarter years.

摘要

在无活动性临床疾病的情况下,系统性红斑狼疮(SLE)血清学检查异常的意义尚不清楚。在本报告中,我们描述了一组14例SLE患者,其临床和血清学特征之间存在明显不一致。这些患者的红斑狼疮细胞检查和抗核抗体试验持续呈阳性,血清补体水平低,DNA结合水平高。他们对刀豆球蛋白A(Con A)促细胞分裂剂的淋巴细胞反应受到抑制。他们一直无症状,平均未接受治疗达四年零三个月。

相似文献

1
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.血清学活动的临床静止系统性红斑狼疮:临床与血清学特征之间的不一致
Am J Med. 1979 Feb;66(2):210-5. doi: 10.1016/0002-9343(79)90529-1.
2
Clinically active serologically quiescent systemic lupus erythematosus.临床活动但血清学静止的系统性红斑狼疮
J Rheumatol. 2003 Sep;30(9):1960-2.
3
Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus.抗天然DNA抗体与血清补体(C3)水平。在系统性红斑狼疮诊断与分类中的应用。
Am J Med. 1983 Feb;74(2):206-16. doi: 10.1016/0002-9343(83)90613-7.
4
The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis.抗核因子延迟出现与肾小球肾炎中系统性红斑狼疮的诊断
Postgrad Med J. 1979 Oct;55(648):723-7. doi: 10.1136/pgmj.55.648.723.
5
Diagnosis and management of systemic lupus erythematosus.系统性红斑狼疮的诊断与管理
Am Fam Physician. 1978 Jan;17(1):133-8.
6
Systemic lupus erythematosus glomerulonephritis in children.儿童系统性红斑狼疮性肾小球肾炎
Paediatrician. 1981;10(5-6):351-67.
7
Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.系统性红斑狼疮中抗核抗体、抗DNA抗体水平与补体之间的相关性
Acta Med Hung. 1988;45(2):145-59.
8
Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.持续性血清学活动但临床无症状的系统性红斑狼疮:频率与结局。
J Rheumatol. 2010 Sep;37(9):1822-7. doi: 10.3899/jrheum.100007. Epub 2010 Jul 1.
9
Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.隐匿性特发性肾小球肾炎患者中的迟发性系统性红斑狼疮及狼疮样疾病
Q J Med. 1983 Autumn;52(208):471-87.
10
Relationship between antibodies to dsDNA and to soluble cellular antigens and histologically defined glomerulonephritis in patients with SLE.
Autoimmunity. 1990;7(1):13-21. doi: 10.3109/08916939009041046.

引用本文的文献

1
Exploring the clinical characteristics and long-term outcome of serologically active clinically quiescent IgG4-related disease: knowledge from a prospective cohort.探索血清学活动但临床静止的IgG4相关疾病的临床特征和长期预后:来自一项前瞻性队列研究的知识
Clin Rheumatol. 2025 May 30. doi: 10.1007/s10067-025-07507-8.
2
Short-term incremental prednisone therapy in patients with serologically active clinically quiescent lupus nephritis: a retrospective observational study.血清学活动但临床静止性狼疮肾炎患者的短期递增泼尼松治疗:一项回顾性观察研究。
Eur J Med Res. 2024 Nov 20;29(1):555. doi: 10.1186/s40001-024-02150-6.
3
No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study.
血清学活动但临床无活动的系统性红斑狼疮患者中,治疗升级对预防疾病复发无明显影响:一项回顾性队列研究。
Rheumatol Int. 2024 Nov;44(11):2411-2419. doi: 10.1007/s00296-024-05593-6. Epub 2024 Apr 26.
4
Predictors of severe lupus flare: a prospective follow-up study.严重狼疮发作的预测因素:一项前瞻性随访研究。
BMC Rheumatol. 2023 May 24;7(1):10. doi: 10.1186/s41927-023-00333-y.
5
Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream.系统性红斑狼疮的达标治疗:现实还是空想。
J Clin Med. 2023 May 8;12(9):3348. doi: 10.3390/jcm12093348.
6
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?2021 年 DORIS 定义下的系统性红斑狼疮缓解与治疗风湿病医生的判断是否相符?
Rheumatology (Oxford). 2024 Jan 4;63(1):72-78. doi: 10.1093/rheumatology/kead159.
7
2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists.2022年临床实践中的系统性红斑狼疮缓解。致波兰风湿病学家的信息。
Reumatologia. 2022;60(2):125-132. doi: 10.5114/reum.2022.115667. Epub 2022 May 18.
8
The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis.抗 DNA 抗体:它们对独特 DNA 结构的特异性及其未解决的临床影响——系统批判和假说。
Front Immunol. 2022 Jan 11;12:808008. doi: 10.3389/fimmu.2021.808008. eCollection 2021.
9
Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study.血清学活动但临床无活动的系统性红斑狼疮中国患者的治疗和结局:一项回顾性观察研究。
Arthritis Res Ther. 2021 Oct 29;23(1):275. doi: 10.1186/s13075-021-02641-5.
10
Follow-up and management of serologically active clinically quiescent cases in pediatric systemic lupus erythematosus.儿童系统性红斑狼疮血清学活动但临床静止病例的随访与管理
Reumatologia. 2021;59(4):244-251. doi: 10.5114/reum.2021.108353. Epub 2021 Aug 13.